Buys
Open market- Shares
- Avg price
- Total value
Nancy E. Denyes - General Counsel at aTYR PHARMA INC
Issuer-level insider activity
- Role
- General Counsel
- Issuer ticker
- ATYR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Nancy E. Denyes in aTYR PHARMA INC
Sells
Open market- Shares
- -1,118
- Avg price
- $0.9761
- Total value
- -$1,091
Net
Past year- Shares
- -1,118
- Share %
- -100%
- Total value
- -$1,091
Reported holdings for Nancy E. Denyes in aTYR PHARMA INC
Form 4 holding
General Counsel
aTYR PHARMA INC
- Security class
- Common Stock
- Shares / value
- 33,124
- Estimated value
- $32,332
- Report date
- 04 Feb 2026
- Price
- $0.9761
- Ownership
- Direct
Form 4 holding
General Counsel
aTYR PHARMA INC
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- $10,157
- Report date
- 03 Feb 2026
- Price
- $3.78
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
General Counsel
aTYR PHARMA INC
- Security class
- Employee Stock Options (right to buy)
- Shares / value
- 412,500
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Nancy E. Denyes in aTYR PHARMA INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.